PathXL to Resell Visiopharm’s Digital Pathology Solutions, Tissuemorph and Visiomorph

Partnership in the European market

Belfast, Northern Ireland and Hørsholm, Denmark
November, 2011

PathXL, a leading provider of Digital Pathology Workflow solutions, and Visiopharm, a leading technology provider of advanced software for quantitative image analysis solutions for life sciences, today announced a partnership in which PathXL will market Visiopharm’s Digital Pathology Solutions in Europe on a non-exclusive basis.

Aiming for a closer collaboration in the digital pathology market, PathXL will become a re-seller of Visiopharm’s toolboxes for advanced image analysis Visiomorph^DP and Tissuemorph^DP. The image analysis tools are integrated with PathXL’s data management software, which offers a suite of specialist applications enabling users to upload, archive, search, share, collaborate, analyse, score and report on huge volumes of pathology data, without worrying about performance, security or ease of use and without getting locked into expensive proprietary standards and systems . The PathXL software can be provided as a hosted service over the web, enabling clients to experience the value of digital pathology, without the overhead of managing their own platform or the need for major capital outlay. 

Visiopharm’s software for Digital Pathology provides efficient tools for extracting morphometric data from whole slide images. It is specifically designed for assisting pathologists in quantification of histological endpoints, such as positive nuclei, membrane intensity and biomarker scoring. The pathologist can work in true stain space and the knowledge and decisions by the pathologist can be easily stored electronically as user defined application protocols. These application protocols can be loaded and executed by any authorized operator.

Des Speed, CEO of PathXL says,

“We are delighted to enter this strategic partnership with Visiopharm. PathXL are specialists in delivering broad digital pathology platforms and workflows to support individual pathologists, pathology organisations and collaborating groups. We are excited to be able to provide our customers with advanced and flexible tools for image analysis, which require low computational power. This allows the pathologist to perform his analysis of whole slide images on his laptop at any time and location”.

Michael Grunkin, CEO of Visiopharm states:

“Quantitative analysis of digital images enables a transformational change of anatomical pathology from a descriptive discipline to one that is quantitative. Providing such image analysis tools for pathologists can dramatically reduce cost and manual labor, increase throughput, standardize data, and ultimately provide knowledge of critical importance to drug development, diagnosis and basic research. The ultimate vision of digital pathology is to provide a seamless workflow from tissue preparation to histo-morphometric endpoints. Combining the software from PathXL and Visiopharm is an important step in that direction”.

About PathXL

PathXL specialises in web-based software and workflows for Digital Pathology. Its PathXL™ Manager product provides a robust, secure and open web-based platform to enable digital pathology users across all fields to manage, view and collaborate around virtual slides easily and efficiently. In addition, PathXL provides a range of applications and workflows on top of PathXL™ Manager to deliver specific solutions to pathologists, scientists and students in Education, Research, Clinical and Biobanking settings. PathXL also provides a full range of supporting services, including scanning, hosting, image analysis and consultancy. PathXL operates in the UK, Europe and North America.

PathXL is a privately owned company, headquartered in Belfast, Northern Ireland. For more information please visit: www.pathxl.com

About Visiopharm

Visiopharm provides advanced analysis software for digital pathology.

The Whole Slide Informatics™ platform from Visiopharm® combines image analysis and stereology on the same software platform, making it possible to obtain valid and unbiased quantitative data both in the 2- and 3- dimensional space by analysis of planar tissue sections.

The image analysis tools VisiomorphDP and TissuemorphDP provide solutions for both clinical and pre-clinical research applications with flexibility, robustness, and low computational costs even for complex analysis. With a novel approach to setting up image analysis protocols, typical image analysis problems such as quantifying nuclear, membrane, and cytoplasmic markers can be addressed effectively with just a few hours of training.

Visiopharm's patented Whole Slide Stereology solutions automate the time-consuming parts of classical stereology methods, helping the researcher to perform stereological analysis significantly faster and more efficiently than with classical stereology.

Our software solutions are designed to operate on all major scanner brands on the market and a wide variety of classical microscopes.

Visiopharm is a privately owned company, with headquarters in Medicon Valley, Denmark, one of the strongest bio-regions in Europe. For more information please visit: www.visiopharm.com